As L-MYC and MYCN (also referred to as N-MYC) are MYC family members, it prompted us to investigate whether DNA-PKcs inhibitor (henceforth, DNA-PKi) could inhibit the cell growth of MYCN-amplified neuroblastoma. The gene discussed is MYCN; the disease is neuroblastoma.